Insights into the impact of microbiota in the treatment of nafld/nash and its potential as a biomarker for prognosis and diagnosis

HIGHLIGHTS

• who: Julio Plaza-Díaz and collaborators from the Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, Granada, Spain have published the article: Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis, in the Journal: Biomedicines 2021, 9, 145. of /2021/
• what: In the present review the authors aim to: (a) summarize studies on both human and animals addressed to determine the impact of alterations in gut microbiota in NASH; (b) evaluate the role of such alterations . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.